Researchers have discovered how a linkage between two proteins in AML enables cancer cells to resist chemotherapy- disrupting the linkage could become a treatment pathway.
Higher doses of hydroxyurea in children with sickle cell disease boosts their fetal hemoglobin levels and significantly reduces hospitalizations.
A newly identified component of the Sonic Hedgehog pathway offers another target for precision medicine for treatment of SHH medulloblastoma subtype
The flu shot may not protect pediatric leukemia patients from influenza during cancer treatment, highlighting the need for additional safeguards.
Despite the fertility risk, most young male cancer patients don’t bank sperm before beginning cancer treatment.
New treatment strategies to overcome drug resistance in chronic myelogenous leukemia and other cancers will come from the detailed structure of the enzyme Abl.
How many blood-forming stem cells are present at birth to keep us supplied with blood cells for a lifetime? It is more than previously thought.
Prophylactic antibiotic therapy with levofloxacin is safe and effective for reducing treatment-related infections in pediatric leukemia patients.
The severity and complexity of chronic disease in adult survivors of childhood cancer suggest that a new approach to healthcare delivery is needed.
Childhood Solid Tumor Network offers the world’s largest and most comprehensive collection of scientific resources for studying pediatric solid tumors
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators.